Creatinine Clearance Calculator
Calculate creatinine clearance (CrCl) with the Cockcroft-Gault formula using age, weight, sex, and serum creatinine — the standard for renal drug dosing.
Creatinine Clearance Calculator
This calculator estimates creatinine clearance (CrCl) using the Cockcroft-Gault formula, from age, body weight, sex, and serum creatinine. It is the calculation most commonly embedded in drug-dosing tables — the estimate clinicians use to adjust doses of many medications that are cleared by the kidneys.
Creatinine clearance estimates how well the kidneys filter creatinine, a waste product of muscle metabolism. The Cockcroft-Gault equation, published in 1976 by Donald Cockcroft and Henry Gault, was derived from a study of 249 patients aged 18 to 92 and predicts creatinine clearance from age, weight, sex, and serum creatinine. It includes a 15% reduction for females, reflecting their typically lower muscle mass relative to body weight[cockcroft-gault-1976].
The distinction from estimated GFR (eGFR) matters. eGFR (typically the CKD-EPI equation) is normalized to a standard body surface area of 1.73 m² and is the recommended measure for staging chronic kidney disease. Cockcroft-Gault, by contrast, is not normalized — it uses actual body weight and returns a value in mL/min that reflects the individual's size. This makes it the formula historically used for dosing renally-cleared drugs, because a drug dose depends on the actual clearance capacity, not a size-normalized value[cockcroft-gault-1976][niddk-ckd].
This is an educational tool, not a diagnosis. Drug dosing decisions must be made by a qualified healthcare professional using the complete clinical picture.
Creatinine clearance is one piece of the renal and metabolic picture this site covers. The GFR Calculator estimates glomerular filtration rate with the more modern CKD-EPI equation, the Corrected Calcium Calculator addresses the electrolyte disturbances that can accompany renal impairment, and the QTc Calculator monitors the heart-rhythm risk of drugs that accumulate when clearance is reduced. The BMI Calculator provides the body-composition baseline used in interpreting dose adjustments.
Enter age, weight, sex, and serum creatinine, and the result updates instantly.
- Age (years) — Cockcroft-Gault is validated in adults.
- Weight (kg) — uses actual body weight (not ideal/adjusted, not normalized).
- Serum creatinine (mg/dL) — from a recent blood test. If your lab reports in μmol/L, divide by 88.4 to get mg/dL.
- Sex — applies the 0.85 female factor.
Example 1 — the standard case. Male, 70 years, 80 kg, serum creatinine 1.5 mg/dL. CrCl = ((140 − 70) × 80) / (72 × 1.5) = 5600 / 108 = 51.9 mL/min (no female factor).
Example 2 — female. Female, 70 years, 80 kg, serum creatinine 1.5 mg/dL. CrCl = 51.9 × 0.85 = 44.1 mL/min. The female factor reduces the estimate because of lower average muscle mass relative to weight[cockcroft-gault-1976].
Example 3 — younger adult. Male, 40 years, 75 kg, serum creatinine 1.0 mg/dL. CrCl = ((140 − 40) × 75) / (72 × 1.0) = 7500 / 72 = 104.2 mL/min — a normal clearance for a younger adult.
The Cockcroft-Gault equation estimates creatinine clearance in mL/min:
where the sex factor is 0.85 for females and 1.0 for males[cockcroft-gault-1976].
Important: this formula requires serum creatinine in mg/dL. If your lab reports creatinine in μmol/L, convert by dividing by 88.4 before entering it.
Why Cockcroft-Gault is not the same as eGFR
The Cockcroft-Gault result is not normalized to body surface area. It reflects the individual's actual clearance capacity, scaled by their real body weight. By contrast, the CKD-EPI equation returns eGFR in mL/min/1.73 m² — normalized to a standard body size so it can be compared across people[inker-2021].
This distinction drives the two uses:
- Drug dosing — historically based on Cockcroft-Gault, because a renally-cleared drug's dose depends on the person's actual clearance.
- CKD staging — based on eGFR (CKD-EPI), normalized for comparability. The National Kidney Foundation provides the reference ranges and staging guidance for eGFR[nkf-egfr].
The choice of formula can change the clinical interpretation. A 45-year-old woman weighing 70 kg with creatinine 1.0 mg/dL has a Cockcroft-Gault CrCl of ~79 mL/min but a CKD-EPI eGFR of ~71 mL/min/1.73 m² — two different numbers answering two different questions[inker-2021].
The practical consequence is that the two measures can place a patient in different drug-dosing buckets. Consider an older, larger adult: a 78-year-old man weighing 95 kg with creatinine 1.4 mg/dL has a Cockcroft-Gault CrCl of about 58 mL/min but a CKD-EPI eGFR of roughly 55 mL/min/1.73 m² — similar, but not identical. In a leaner, older patient the gap widens, because Cockcroft-Gault is sensitive to body weight while CKD-EPI is normalized to a standard body size. Drug labels that specify dosing by "CrCl 30–50" versus "eGFR 30–50" are not interchangeable; using the wrong measure can lead to under- or over-dosing a renally-cleared drug. This is why knowing which formula a reference assumes, and entering accurate weight and creatinine, is essential[awdishu-2025].
A note on current guidance (KDIGO 2024)
KDIGO 2024 recommends the race-free CKD-EPI equation (not Cockcroft-Gault) for drug dosing when precision matters, and recommends eGFR-based dosing over creatinine clearance in many settings[awdishu-2025][kdigo-2024]. However, Cockcroft-Gault remains embedded in many drug-label dosing tables and is still widely used in clinical practice, so it remains worth calculating and understanding. The GFR Calculator provides the CKD-EPI estimate for staging; this calculator provides the Cockcroft-Gault estimate for dosing context.
Step 1 — gather inputs. Age 70, weight 80 kg, serum creatinine 1.5 mg/dL, male.
Step 2 — compute the numerator. (140 − 70) × 80 = 70 × 80 = 5600.
Step 3 — compute the denominator. 72 × 1.5 = 108.
Step 4 — divide. 5600 / 108 = 51.9 mL/min.
Step 5 — apply the sex factor. Male → × 1.0 → 51.9 mL/min.
Step 6 — interpret. A CrCl of ~52 mL/min suggests moderately reduced renal clearance. For drug dosing, many references use ranges (e.g., >50, 30–50, <30 mL/min) to guide dose adjustment — a clinician applies the relevant drug's specific criteria[fda-renal].
The table shows how creatinine clearance changes with age, weight, sex, and creatinine (serum creatinine 1.0 mg/dL unless noted):
| 40 | 75 | Male | 104.2 | Younger adult, normal |
| 55 | 75 | Male | 88.5 | Declining with age |
| 70 | 80 | Male | 77.8 | Older adult |
| 70 | 80 | Female | 66.1 | Female factor 0.85 |
| 70 | 80 | Male (Scr 1.5) | 51.9 | Higher creatinine |
| 70 | 60 | Male | 58.3 | Lower weight |
Two patterns stand out. First, clearance declines with age — the (140 − age) term means each year of age lowers the estimate. Second, the female factor (0.85) and a higher serum creatinine both reduce the estimate substantially, which is why weight and accurate creatinine matter so much for drug dosing[cockcroft-gault-1976].
- Use real body weight — usually. Cockcroft-Gault was derived with actual body weight. At extremes of obesity or cachexia, ideal or adjusted body weight may be more appropriate; many references advise adjusted weight for BMI >30[fda-renal].
- Convert units first. The formula requires creatinine in mg/dL. If your lab uses μmol/L, divide by 88.4. A unit error changes the result by ~88×.
- Know which formula is being used. CrCl (Cockcroft-Gault) and eGFR (CKD-EPI) are different numbers answering different questions. Dosing tables usually specify which one they assume — match them[awdishu-2025].
- Requires steady-state creatinine. The formula is invalid in acute kidney injury or rapidly changing kidney function, where creatinine has not reached equilibrium[niddk-ckd].
- Not validated under 18. Cockcroft-Gault was derived in adults; pediatric kidney function is estimated differently.
- KDIGO 2024 prefers CKD-EPI for staging and increasingly for dosing. Use this calculator for context, but follow current institutional guidance on which formula to apply for a specific drug[kdigo-2024].
- Match the dosing-table units. A dosing table that says "reduce dose if CrCl < 30" is almost always referring to Cockcroft-Gault in mL/min; one that says "eGFR < 30" refers to CKD-EPI in mL/min/1.73 m². Read the drug's label to see which measure it uses, and enter the matching inputs[fda-renal].
- Re-check creatinine on changes in status. Because the formula requires a steady state, a creatinine drawn during an acute illness or after starting or stopping a medication that affects it may not reflect the patient's baseline. A clinician should re-evaluate with a fresh creatinine when kidney function may have changed[niddk-ckd].
- It is not a diagnosis and not a dosing order. It estimates creatinine clearance; it does not recommend a specific drug dose. Dose adjustment requires a clinician applying the drug's approved criteria[fda-renal].
- Cockcroft-Gault is not normalized to body surface area. It overestimates clearance in obesity and underestimates it in low muscle mass, because it depends on total body weight.
- It assumes a steady state. In acute kidney injury, rapidly changing creatinine, or unstable patients, the estimate is unreliable[niddk-ckd].
- It predates modern creatinine standardization. Cockcroft-Gault was developed before IDMS-calibrated creatinine assays; modern CKD-EPI is calibrated to IDMS standards, so results may differ between the two formulas for the same patient[inker-2021].
- KDIGO 2024 recommends CKD-EPI over Cockcroft-Gault in many settings. This calculator is provided for the many drug tables that still reference Cockcroft-Gault, but it is not the preferred general measure of kidney function[kdigo-2024].
- Not for children, pregnancy, or extremes of body habitus without clinician guidance. Pediatric renal function is estimated with age-adjusted equations, and pregnancy changes kidney function substantially.
- ❓ What is creatinine clearance?
- ✅ Creatinine clearance estimates how well the kidneys filter creatinine, a waste product of muscle metabolism. It is expressed in mL/min and is used primarily for dosing drugs that are cleared by the kidneys. The Cockcroft-Gault formula estimates it from age, weight, sex, and serum creatinine.
- ❓ What is the Cockcroft-Gault formula?
- ✅ CrCl = ((140 − age) × weight in kg) / (72 × serum creatinine in mg/dL), multiplied by 0.85 for females and 1.0 for males. It was published in 1976 and is widely used in drug-dosing tables.
- ❓ What is the difference between creatinine clearance and eGFR?
- ✅ Creatinine clearance (Cockcroft-Gault) is not normalized to body surface area and reflects actual clearance for drug dosing. eGFR (CKD-EPI) is normalized to 1.73 m² and is used for staging chronic kidney disease. They answer different clinical questions and can give different numbers.
- ❓ Why is there a female factor in Cockcroft-Gault?
- ✅ Because, on average, females have lower muscle mass relative to body weight, and creatinine comes from muscle. The original study found creatinine clearance about 15% lower in females, so the formula applies a 0.85 factor.
- ❓ What is a normal creatinine clearance?
- ✅ There is no single 'normal' value; clearance declines with age and varies with body size. Younger adults often have CrCl around 90–140 mL/min. Because it is not normalized, interpreting it requires the individual's context. Drug-dosing ranges (e.g., >50, 30–50, <30 mL/min) are what matter for dosing.
- ❓ Should I use Cockcroft-Gault or CKD-EPI for drug dosing?
- ✅ Many drug labels still reference Cockcroft-Gault, so it remains clinically used. However, KDIGO 2024 recommends the race-free CKD-EPI equation for drug dosing when precision matters, and increasingly recommends eGFR-based dosing. Follow current institutional guidance.
- ❓ How do I convert creatinine from μmol/L to mg/dL?
- ✅ Divide by 88.4. The Cockcroft-Gault formula requires serum creatinine in mg/dL; if your lab reports μmol/L, convert before entering the value. A unit error changes the result by roughly 88×.
- ❓ Is this calculator for dosing medications?
- ✅ No. This is an educational tool that estimates creatinine clearance; it does not recommend specific drug doses. Medication dosing must be determined by a qualified healthcare professional applying the drug's approved criteria to the full clinical picture.
References
- [1]Cockcroft, D.W., & Gault, M.H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31–41.
- [2]Inker, L.A., et al. (2021). New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. New England Journal of Medicine, 385, 1737–1749.
- [3]Kidney Disease: Improving Global Outcomes (KDIGO). (2024). Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4S).
- [4]Awdishu, L., et al. (2025). KDIGO 2024 CKD guideline: implications for pharmacy practice. American Journal of Health-System Pharmacy, 82, 660–671.
- [5]U.S. Food and Drug Administration. (2024). Pharmacokinetics in Patients with Impaired Renal Function.
- [6]National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). (2026). Chronic Kidney Disease: Tests & Diagnosis.
- [7]National Kidney Foundation. (2026). Estimated GFR (eGFR).
Last updated: August 17, 2026
UnByte — Independent Software Engineering
Every calculator references authoritative sources — Editorial policy
